Patent · US Active

Inhibitors of ROR gamma

US11186573B2 · kind B2 · utility

0Cited by

40References

6Claims

0Family size

Assignee

Vitae Pharmaceuticals, LLC · US

Inventors

Chaoyi Deng · Shanghai, CN
Jun He · Shanghai, CN
Bo Xu · Beijing, CN

Key dates

Filing date	Jul 24, 2018
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Jul 24, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure relates to salts and crystalline forms of a compound having the formula (I): Also described are processes for the production of the salts and crystalline forms described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.